China Rehabilitation Research Center Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00725790
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

China Rehabilitaition Research Center | China Rehabilitation and Research Center | China Rehabilitation Research Center

Active Ingredients

Drugs in Phase 4 Trials (1)

vardenafil (levitra) (1 trial)

Drugs in Phase 2 Trials (1)

lithium (lithonate) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erectile Dysfunction (Phase 4)

Neuralgia (Phase 2)

Spinal Cord Injuries (Phase 4)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 2